Hoya Reports Third Quarter Financial Results: Record High Revenues
TOKYO Hoya Corporation (TOKYO:7741) today announced financial results for the third quarter ended December 31, 2017. During the quarter, revenues for the HOYA Group increased 11.6% year on year,...
View ArticleVisioneering Technologies Achieves CE Mark for NaturalVue® Family of 1 Day...
ATLANTA Visioneering Technologies, Inc. (ASX: VTI), an innovative US-based medical device company dedicated to developing advanced products that improve vision, announced today receipt of the...
View ArticleBrandeis International Business School Announces Finalists for Inaugural...
WALTHAM, Mass. Brandeis International Business School today announced the five global finalists that will move forward in the inaugural Smart Fifty competition, an entrepreneurial competition...
View ArticleSecond Sight Medical Products, Inc. to Present at the B. Riley & Co. China...
SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to...
View Articleソウル半導体の太陽光LED “SunLike”、中国イーライトのスマートランプに採用
韓国安山市 (ビジネスワイヤ) — 世界的なLED (発光ダイオード)専業メーカーのSeoul Semiconductor Co., Ltd. (本社:韓国安山市、代表理事:李貞勲、以下「ソウル半導体」)は、革新的なIT専門企業シャオミ(Xiaomi)社のエコチェーンカンパニーであり、インテリジェント照明業界のリーダーであるYeelight (www.yeelight.com、代表:Jiang...
View Articleソウル半導体、欧州で「ヒューマンセントリック照明と健康」をテーマとするシンポジウムを開催
韓国安山市 (ビジネスワイヤ) — 世界的なLED (発光ダイオード)専業メーカーのSeoul Semiconductor Co., Ltd. (本社:韓国安山市、代表理事:李貞勲、以下「ソウル半導体」)は、光が健康と生体リズムに与える影響を、科学的、客観的に究明したシンポジウムを、世界最大級の照明展示会Light &...
View ArticleSwiss Advanced Vision上市用于白内障手术的实时自动对焦主动式人工晶体概念
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 瑞士纳沙泰尔 (美国商业资讯) — Swiss Advanced Vision (SAV-IOL)宣布启动R-TASC项目,以此搅局全球人工晶体(IOL)市场。 本新闻稿包含多媒体。此处查看新闻稿全文:...
View ArticleSwiss Advanced Visionが白内障向けにリアルタイムのオートフォーカス機能を搭載した能動眼内レンズ構想を発表
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 スイス・ヌーシャテル (ビジネスワイヤ)– Swiss Advanced Vision(SAV-IOL)は、世界の眼内レンズ(IOL)市場を根底から変革することになるR-TASCプロジェクトの発足について発表しました。...
View ArticleAvedro宣布融资2500万美元用于推动创新和商业增长
马萨诸塞州沃尔瑟姆 (美国商业资讯) — 眼科药品和医疗器械公司、角膜重塑领域的世界领先者Avedro, Inc.今天宣布已争取到2500万美元的融资,该融资由Lilly Asia Ventures (LAV)领投,主要跟投者来自于现有的投资者OrbiMed Advisors、InterWest Partners和HealthQuest...
View ArticleSTAAR Surgical and Kobe Kanagawa Eye Clinic in Japan Announce Strategic...
MONROVIA, Calif. STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, and Kobe Kanagawa Eye Clinic...
View Articleソウル半導体の自然光LED、臨床試験で、目の疲労や睡眠の質に効果
韓国安山市 世界的なLED (発光ダイオード)専業メーカーのSeoul Semiconductor Co., Ltd. (本社:韓国安山市、代表理事:李貞勲、以下「ソウル半導体」)は、自社の先端技術で開発した自然光LEDの”SunLike”が睡眠の質の向上と目の健康に有益な、ヒューマンセントリック照明に最適化されたLED製品であるという研究結果が出たと発表した。...
View Article首尔半导体的LED “SunLike”产品临床试验结果显示:对眼部健康和睡眠质量具有改善效果
韩国 安山 全球领先的LED企业首尔半导体(KOSDAQ 046890)宣布:临床试验证明,以人为本的照明产品“SunLike“对眼部健康的睡眠质量具有改善效果。 本新闻稿包含多媒体。此处查看新闻稿全文: https://www.businesswire.com/news/home/20180716005219/zh-CN/ 降低蓝光峰值的SunLike光谱 (图示:美国商业资讯)...
View ArticleGlaukos Announces Pharmaceutical Development Agreement with D. Western...
SAN CLEMENTE, Calif. Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and...
View ArticleACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License...
SAN DIEGO & MELBOURNE, Australia ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) and Neuren Pharmaceuticals Limited (ASX: NEU) announced today that they have entered into an exclusive North American...
View ArticleSTAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic...
MONROVIA, Calif. STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, and Dr. Maro Kariya of...
View ArticlePatient-Driven Gene Therapy Company ReflectionBio Receives Orphan Drug...
HONG KONG & NEW YORK Reflection Biotechnologies Limited (“ReflectionBio”), a gene therapy company committed to the research and development of life-changing treatments for rare diseases, today...
View ArticlePolyActiva Commences Its First Phase I Clinical Trial with Potential to...
MELBOURNE, Australia PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently recruited first patients into its Phase I clinical study designed to show its glaucoma...
View ArticleSwiss Advanced Vision上市Harmonis – 首款用于白内障手术的可定制EDOF人工晶体
瑞士纳沙泰尔 (美国商业资讯) — Swiss Advanced Vision...
View ArticleSwiss Advanced Visionが初のカスタマイズ可能な白内障手術用EDOF IOLとなるHarmonisを発表
スイス・ヌーシャテル (ビジネスワイヤ) — Swiss Advanced...
View ArticleVisioneering Announces First International Revenues and Attendance at Myopia...
ATLANTA Normally, one could expect a lag between accounts signing up and revenue starting from those accounts, but shortly after signing Visioneering Technologies’, Inc. (ASX: VTI) first...
View Article